Tag: #cancer

Pirtobrutinib Triplet Prolongs Progression-Free Survival in Previously Treated CLL, Lancet Reports

Phase 3 BRUIN CLL-322 found fixed-duration pirtobrutinib with venetoclax–rituximab cut progression/death risk by ~45% vs venetoclax–rituximab in relapsed CLL.

$LLY, #cancer, #cll, #hematology, #pirtobrutinib

WHO Projects Global Cancer Cases Could Reach Nearly 35 Million by 2050, Warns of Growing Inequities

WHO projects new cancer cases from 20.6M (2024) to nearly 35M by 2050, warning low-income countries will bear the heaviest burden without stronger prevention.

#cancer, #who, #globalhealth, #publichealth

NHS England rolls out 60-second pembrolizumab injection to cut treatment chair time

NHS England is introducing a subcutaneous form of pembrolizumab (Keytruda) that can be given in about a minute, reducing clinic time for roughly 14,000 patients.

#nhs, #pembrolizumab, #cancer, #immunotherapy

Brazil's new cancer framework promises free advanced therapies through SUS and a push for domestic production

Brazil approved a framework to expand free access to advanced cancer therapies via SUS, speed regulatory reviews and favor domestic production.

#brazil, #healthcare, #cancer, #anvisa